Results 71 to 80 of about 274,125 (232)

Ospemifene: A Novel Oral Therapy for Vulvovaginal Atrophy of Menopause [PDF]

Journal of Obstetrics and Gynaecology Canada, 2020
Vulvovaginal atrophy (VVA) resulting from estrogen deprivation at menopause often results in distressing vaginal dryness and dyspareunia. Fewer than 25% of affected women seek help for this condition citing embarrassment, cultural values, an aging or unavailable partner and concerns about use of estrogens following the Women's Health Initiative ...
Robert L. Reid, Denise Black, Christine Derzko, David Portman   +3 more
openaire   +2 more sources

Laterally Extended Endopelvic Resection (Leer) and Reconstructive Techniques for Treatment of Locally Advanced Cervix Cancer: A Case Report [PDF]

, 2016
The aim of this report is to describe the surgical procedure done in a 24-year-old woman who presents a locally advanced squamous cervix carcinoma and is proposed to laterally extended endopelvic resection (LEER), intraoperative radiation therapy with ...
Barres, Jordan, Boucher, Anna, Cañete Mota, A., De Francia, Stephan, Escrig-Sos, Javier, Ferrer, Carlos, Gimeno, Anna, Guijarro Colomer, M., Herraiz Roda, José Luis, Llueca, Antoni, Maazouzi, Yasmine, Medina, Carmen, Piquer Simó, Dolors, Rodrigo, Miguel, Serra Rubert, Anna   +14 more
core   +1 more source

The effects of royal jelly on human health: A narrative review of clinical studies

JSFA reports, EarlyView.
Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Goras Georgios, Thrasyvoulou Andreas, Tsilimpokou Evanthia   +2 more
wiley   +1 more source

Menopausal hormone therapy [PDF]

, 2007
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
Pardini, Dolores
core   +2 more sources

The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Pelvic organ prolapse (POP) affects up to 50% of postmenopausal women, negatively impacting sexual function and quality of life. While surgery remains the primary treatment, increasing attention has been given to perioperative vaginal oestrogen therapy and its potential impact on surgical outcomes.
Gilda Sicilia, Salvatore Giovanni Vitale, Maurizio Nicola D'Alterio, Stefania Saponara, Francesco Scicchitano, Anna Maria Fulghesu, Rossella E. Nappi, Stefano Angioni   +7 more
wiley   +1 more source

Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA

Climacteric, 2023
This study aimed to evaluate the self-reported satisfaction of Spanish postmenopausal women currently treated for vulvovaginal atrophy (VVA) symptoms.The CRETA (CRoss sectional European sTudy on Adherence) is a multicenter cross-sectional study conducted in 29 public and private hospitals in Spain, which enrolled postmenopausal women receiving ...
R. Sánchez-Borrego, M. V. de Diego Pérez de Zabalza, M. J. Alfageme Gullón, M. L. Alija Castrillo, M. Sánchez Prieto, S. Palacios, A. J. González Calvo, J. J. Quijano Martín, M. J. Cancelo   +8 more
openaire   +2 more sources

Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors. [PDF]

, 2021
Adjuvant chemotherapy and endocrine therapy can induce early iatrogenic menopause or worsen pre-existing menopausal symptoms in breast cancer survivors (BCS).
Fabrizio Bert, Gian Piero Siliquini, Lorenzo Novara, Margherita Giorgi, Nicoletta Biglia, Valentina Elisabetta Bounous   +5 more
core   +1 more source

Modern Management of the Menopause: Are We Measuring What Matters?

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Assess uptake of the Core Outcomes in Menopause (COMMA) core outcome sets (COS) and examine whether frontline treatments for vasomotor and genitourinary symptoms have been evaluated against these key outcomes. Design Methodological review. Setting Published literature and international clinical trial registries.
Joscelyn Gan, Michelle Steeper, Tim Hillard, Monica Christmas, Jan Shifren, Nick Panay, Martha Hickey, Sarah Lensen   +7 more
wiley   +1 more source

Carbon Dioxide Laser Vulvovaginal Rejuvenation: A Systematic Review

Cosmetics, 2021
Genitourinary syndrome of menopause (GSM) causes significant symptomatic aggravation that affects the quality of life (QoL). Vulvovaginal atrophy (VVA), the hallmark of GSM, is managed with topical non-hormonal therapy, including moisturizers and ...
Tassahil Messas, Achraf Messas, George Kroumpouzos   +2 more
doaj   +1 more source

The use of topical vaginal estrogens in postpartum women: A systematic review

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
A postpartum reduction in circulating estrogen levels, due to antagonism from elevated prolactin levels, further elevated during breastfeeding, can result in pelvic floor dysfunction, including bladder, bowel and sexual dysfunction, pain and implications for perineal wound healing.
Aysha Waheed, Annika Taithongchai, Dudley Robinson   +2 more
wiley   +1 more source